 Home > Biochemistry News > Biotechnology News > The world's first FRα ADC is expected to submit an FDA Biologics License Application in March

The world's first FRα ADC is expected to submit an FDA Biologics License Application in March

 Last Update: 2022-05-22
 Source: Internet
 Author: User

Tags

tadalafil drug class

gf 9 results

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 20, 2022, Huadong Medicine issued an announcement stating that ImmunoGen, a wholly-owned subsidiary of the company’s Sino-US Huadong-US partner, announced that its organization developed a new class 1 biological drug for the treatment of ovarian cancer, Mirvetuximab Soravtansine (IMGN853, referred to as "" Mirvetuximab") full study results of the US pivotal single-arm clinical trial ("SORAYA trial"): the trial has met the primary endpoint, with a confirmed objective response rate (ORR) of 32.

ImmunoGen expects to file a Biologics License Application (BLA) for Mirvetuximab in the United States this month

Huadong Medicine stated that Mirvetuximab is the world's first FRα-targeted ADC drug and is a key product under development in the company's innovative oncology drug pipeline

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.